Viewing Study NCT00149851


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2026-04-11 @ 7:58 AM
Study NCT ID: NCT00149851
Status: COMPLETED
Last Update Posted: 2010-09-01
First Post: 2005-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CHTF919B2203
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators